STOCK TITAN

[Form 4] NV5 Global, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 08/04/2025, NV5 Global, Inc. (NVEE) Executive Vice President, Chief Administrative Officer & Secretary and Director MaryJo O’Brien filed a Form 4 reporting the disposition of her entire 263,621-share direct holding of NV5 common stock. The shares were automatically converted under the 05/14/2025 Agreement and Plan of Merger between NV5 and Acuren Corporation. Each NV5 share was exchanged for 1.1523 Acuren shares plus $10.00 cash; all outstanding restricted stock vested immediately before the mergers’ effective time and received the same consideration, net of tax withholding. Following the transaction, the insider reports zero NV5 shares owned and no derivative holdings.

The filing signals consummation of the change-of-control transaction and confirms that NV5 equity will be replaced by a cash-and-stock package in Acuren for all shareholders.

Il 08/04/2025, MaryJo O’Brien, Vicepresidente Esecutivo, Chief Administrative Officer, Segretaria e Direttrice di NV5 Global, Inc. (NVEE), ha presentato un Modulo 4 segnalando la cessione dell'intera partecipazione diretta di 263.621 azioni ordinarie NV5. Le azioni sono state automaticamente convertite in base all'Accordo e Piano di Fusione del 14/05/2025 tra NV5 e Acuren Corporation. Ogni azione NV5 è stata scambiata con 1,1523 azioni Acuren più 10,00 dollari in contanti; tutte le azioni vincolate in essere sono state immediatamente liberate prima dell'entrata in vigore della fusione e hanno ricevuto la stessa considerazione, al netto delle ritenute fiscali. Dopo la transazione, l'insider segnala di non possedere più azioni NV5 né strumenti derivati.

La presentazione indica il completamento dell'operazione di cambio di controllo e conferma che il capitale NV5 sarà sostituito da un pacchetto in contanti e azioni Acuren per tutti gli azionisti.

El 08/04/2025, MaryJo O’Brien, Vicepresidenta Ejecutiva, Directora Administrativa y Secretaria y Directora de NV5 Global, Inc. (NVEE), presentó un Formulario 4 informando la disposición de toda su participación directa de 263,621 acciones ordinarias de NV5. Las acciones se convirtieron automáticamente bajo el Acuerdo y Plan de Fusión del 14/05/2025 entre NV5 y Acuren Corporation. Cada acción de NV5 fue intercambiada por 1.1523 acciones de Acuren más 10,00 dólares en efectivo; todas las acciones restringidas pendientes se liberaron inmediatamente antes de la efectividad de la fusión y recibieron la misma compensación, neta de retenciones fiscales. Tras la transacción, la persona con información privilegiada reporta cero acciones de NV5 en propiedad y sin tenencias derivadas.

La presentación señala la consumación de la transacción de cambio de control y confirma que el capital de NV5 será reemplazado por un paquete de efectivo y acciones de Acuren para todos los accionistas.

2025년 4월 8일, NV5 Global, Inc.(NVEE)의 부사장 겸 최고관리책임자 및 이사인 MaryJo O’Brien은 Form 4를 제출하여 자신이 보유한 NV5 보통주 263,621주 전량을 처분했음을 보고했습니다. 해당 주식은 2025년 5월 14일 NV5와 Acuren Corporation 간의 합병 계약 및 계획에 따라 자동으로 전환되었습니다. NV5 주식 1주는 Acuren 주식 1.1523주와 현금 10.00달러로 교환되었으며, 모든 미제한 제한 주식은 합병 발효 직전에 즉시 완전 소유권이 이전되어 동일한 대가를 세금 원천징수 후 받았습니다. 거래 후 내부자는 NV5 주식을 전혀 보유하지 않고 파생상품도 없음을 보고했습니다.

이 제출은 경영권 변경 거래가 완료되었음을 알리며, 모든 주주에게 NV5 주식이 Acuren의 현금 및 주식 패키지로 대체될 것임을 확인합니다.

Le 08/04/2025, MaryJo O’Brien, vice-présidente exécutive, directrice administrative et secrétaire ainsi que membre du conseil d'administration de NV5 Global, Inc. (NVEE), a déposé un Formulaire 4 signalant la cession de l'intégralité de sa détention directe de 263 621 actions ordinaires NV5. Les actions ont été automatiquement converties conformément à l'accord et au plan de fusion du 14/05/2025 entre NV5 et Acuren Corporation. Chaque action NV5 a été échangée contre 1,1523 action Acuren plus 10,00 $ en espèces ; toutes les actions restreintes en circulation ont été immédiatement libérées avant l'entrée en vigueur de la fusion et ont reçu la même contrepartie, nette des retenues fiscales. Après la transaction, l'initié déclare ne plus détenir aucune action NV5 ni de titres dérivés.

Le dépôt indique la réalisation de la transaction de changement de contrôle et confirme que le capital NV5 sera remplacé par un ensemble en espèces et actions Acuren pour tous les actionnaires.

Am 08.04.2025 reichte MaryJo O’Brien, Executive Vice President, Chief Administrative Officer & Secretary sowie Direktorin von NV5 Global, Inc. (NVEE), ein Formular 4 ein, in dem sie die Veräußerung ihres gesamten direkten Bestands von 263.621 NV5-Stammaktien meldete. Die Aktien wurden automatisch gemäß dem Fusionsvertrag und -plan vom 14.05.2025 zwischen NV5 und der Acuren Corporation umgewandelt. Jede NV5-Aktie wurde gegen 1,1523 Acuren-Aktien plus 10,00 USD in bar getauscht; alle ausstehenden eingeschränkten Aktien wurden unmittelbar vor dem Wirksamwerden der Fusion unverzüglich freigegeben und erhielten dieselbe Gegenleistung, abzüglich der Steuerabzüge. Nach der Transaktion meldet der Insider keinen Besitz von NV5-Aktien mehr und keine derivativen Beteiligungen.

Die Meldung signalisiert den Abschluss der Kontrollwechsel-Transaktion und bestätigt, dass das NV5-Eigenkapital für alle Aktionäre durch ein Bar- und Aktienpaket von Acuren ersetzt wird.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider’s Form 4 confirms NV5–Acuren merger closing and full share conversion; impactful for valuation and liquidity.

The automatic conversion of 263,621 insider shares into 1.1523 Acuren shares plus $10 cash per NV5 share evidences final execution of the merger agreement. Because consideration includes a fixed cash element, downside risk for NV5 holders is capped, while upside now tracks Acuren’s performance. The insider’s stake falls to zero, underscoring change-of-control and eliminating potential governance continuity. Investors should focus on exchange ratio economics and Acuren’s post-deal valuation.

TL;DR: Filing is impactful; NV5 equity converts, insider exits, cash element provides partial floor.

This Form 4 is a procedural yet material disclosure: a senior officer’s full divestiture confirms that NV5 shares are effectively retired. Holders receive $10 cash plus 1.1523 Acuren shares, implying blended value contingent on Acuren pricing. The absence of price data limits immediate arbitrage analysis, but the conversion ratio locks relative ownership. Loss of insider ownership could reduce alignment, but post-close governance shifts to Acuren. Overall, the event crystallises value and liquidity, positioning the combined entity for integration risk.

Il 08/04/2025, MaryJo O’Brien, Vicepresidente Esecutivo, Chief Administrative Officer, Segretaria e Direttrice di NV5 Global, Inc. (NVEE), ha presentato un Modulo 4 segnalando la cessione dell'intera partecipazione diretta di 263.621 azioni ordinarie NV5. Le azioni sono state automaticamente convertite in base all'Accordo e Piano di Fusione del 14/05/2025 tra NV5 e Acuren Corporation. Ogni azione NV5 è stata scambiata con 1,1523 azioni Acuren più 10,00 dollari in contanti; tutte le azioni vincolate in essere sono state immediatamente liberate prima dell'entrata in vigore della fusione e hanno ricevuto la stessa considerazione, al netto delle ritenute fiscali. Dopo la transazione, l'insider segnala di non possedere più azioni NV5 né strumenti derivati.

La presentazione indica il completamento dell'operazione di cambio di controllo e conferma che il capitale NV5 sarà sostituito da un pacchetto in contanti e azioni Acuren per tutti gli azionisti.

El 08/04/2025, MaryJo O’Brien, Vicepresidenta Ejecutiva, Directora Administrativa y Secretaria y Directora de NV5 Global, Inc. (NVEE), presentó un Formulario 4 informando la disposición de toda su participación directa de 263,621 acciones ordinarias de NV5. Las acciones se convirtieron automáticamente bajo el Acuerdo y Plan de Fusión del 14/05/2025 entre NV5 y Acuren Corporation. Cada acción de NV5 fue intercambiada por 1.1523 acciones de Acuren más 10,00 dólares en efectivo; todas las acciones restringidas pendientes se liberaron inmediatamente antes de la efectividad de la fusión y recibieron la misma compensación, neta de retenciones fiscales. Tras la transacción, la persona con información privilegiada reporta cero acciones de NV5 en propiedad y sin tenencias derivadas.

La presentación señala la consumación de la transacción de cambio de control y confirma que el capital de NV5 será reemplazado por un paquete de efectivo y acciones de Acuren para todos los accionistas.

2025년 4월 8일, NV5 Global, Inc.(NVEE)의 부사장 겸 최고관리책임자 및 이사인 MaryJo O’Brien은 Form 4를 제출하여 자신이 보유한 NV5 보통주 263,621주 전량을 처분했음을 보고했습니다. 해당 주식은 2025년 5월 14일 NV5와 Acuren Corporation 간의 합병 계약 및 계획에 따라 자동으로 전환되었습니다. NV5 주식 1주는 Acuren 주식 1.1523주와 현금 10.00달러로 교환되었으며, 모든 미제한 제한 주식은 합병 발효 직전에 즉시 완전 소유권이 이전되어 동일한 대가를 세금 원천징수 후 받았습니다. 거래 후 내부자는 NV5 주식을 전혀 보유하지 않고 파생상품도 없음을 보고했습니다.

이 제출은 경영권 변경 거래가 완료되었음을 알리며, 모든 주주에게 NV5 주식이 Acuren의 현금 및 주식 패키지로 대체될 것임을 확인합니다.

Le 08/04/2025, MaryJo O’Brien, vice-présidente exécutive, directrice administrative et secrétaire ainsi que membre du conseil d'administration de NV5 Global, Inc. (NVEE), a déposé un Formulaire 4 signalant la cession de l'intégralité de sa détention directe de 263 621 actions ordinaires NV5. Les actions ont été automatiquement converties conformément à l'accord et au plan de fusion du 14/05/2025 entre NV5 et Acuren Corporation. Chaque action NV5 a été échangée contre 1,1523 action Acuren plus 10,00 $ en espèces ; toutes les actions restreintes en circulation ont été immédiatement libérées avant l'entrée en vigueur de la fusion et ont reçu la même contrepartie, nette des retenues fiscales. Après la transaction, l'initié déclare ne plus détenir aucune action NV5 ni de titres dérivés.

Le dépôt indique la réalisation de la transaction de changement de contrôle et confirme que le capital NV5 sera remplacé par un ensemble en espèces et actions Acuren pour tous les actionnaires.

Am 08.04.2025 reichte MaryJo O’Brien, Executive Vice President, Chief Administrative Officer & Secretary sowie Direktorin von NV5 Global, Inc. (NVEE), ein Formular 4 ein, in dem sie die Veräußerung ihres gesamten direkten Bestands von 263.621 NV5-Stammaktien meldete. Die Aktien wurden automatisch gemäß dem Fusionsvertrag und -plan vom 14.05.2025 zwischen NV5 und der Acuren Corporation umgewandelt. Jede NV5-Aktie wurde gegen 1,1523 Acuren-Aktien plus 10,00 USD in bar getauscht; alle ausstehenden eingeschränkten Aktien wurden unmittelbar vor dem Wirksamwerden der Fusion unverzüglich freigegeben und erhielten dieselbe Gegenleistung, abzüglich der Steuerabzüge. Nach der Transaktion meldet der Insider keinen Besitz von NV5-Aktien mehr und keine derivativen Beteiligungen.

Die Meldung signalisiert den Abschluss der Kontrollwechsel-Transaktion und bestätigt, dass das NV5-Eigenkapital für alle Aktionäre durch ein Bar- und Aktienpaket von Acuren ersetzt wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
O'Brien MaryJo

(Last) (First) (Middle)
200 SOUTH PARK RD.
SUITE 350

(Street)
HOLLYWOOD FL 33021

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NV5 Global, Inc. [ NVEE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Ex VP, Chief Admin & Secretary
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/04/2025 D 263,621 D (1) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.
/s/ MaryJo OBrien 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Nv5 Global Inc

NASDAQ:NVEE

NVEE Rankings

NVEE Latest News

NVEE Latest SEC Filings

NVEE Stock Data

1.51B
57.41M
12.11%
76.03%
2.35%
Engineering & Construction
Services-miscellaneous Business Services
Link
United States
HOLLYWOOD